Cantrixil
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cantrixil, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]